Division of Pediatric Respiratory Medicine, Montreal Children's Hospital-McGill University Health Centre, Montreal, Quebec, Canada.
Paediatr Respir Rev. 2011 Mar;12(1):78-82. doi: 10.1016/j.prrv.2010.09.007. Epub 2010 Oct 30.
Chronic lung disease is a significant source of morbidity and mortality in patients with sickle cell disease. Asthma and sickle cell lung disease share many of the same clinical features and pathophysiological mechanisms. Though there is growing evidence of an association between sickle cell disease and airway hyper-reactivity, there is still no consensus on the definition of asthma in sickle cell lung disease. This review will explore what we know about asthma and airway hyper-reactivity in sickle cell disease and whether currently available asthma therapies may be beneficial in delaying or averting the progression of sickle cell lung disease.
慢性肺部疾病是镰状细胞病患者发病率和死亡率的重要来源。哮喘和镰状细胞肺病具有许多相同的临床特征和病理生理机制。尽管越来越多的证据表明镰状细胞病与气道高反应性之间存在关联,但对于镰状细胞肺病中哮喘的定义仍未达成共识。本文综述将探讨我们对镰状细胞病中哮喘和气道高反应性的了解,以及目前可用的哮喘治疗方法是否可能有助于延缓或避免镰状细胞肺病的进展。